Oakworth Capital, Inc. Viatris Inc Transaction History

Oakworth Capital, Inc.

$1.45 Billion
Q4 2024

A detailed history of Oakworth Capital, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Oakworth Capital, Inc. holds 4,627 shares of VTRS stock, worth $43,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,627

Previous 4,970 6.9%

Holding current value

$43,586

Previous $57,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$11.32 - $13.37 $3,882 - $4,585	-343 Reduced 6.9%	4,627 $57,000
Q3 2024 Oct 21, 2024	BUY	$10.32 - $12.13 $1,269 - $1,491	123 Added 2.54%	4,970 $57,000
Q1 2024 Apr 22, 2024	BUY	$11.27 - $13.53 $3,448 - $4,140	306 Added 6.74%	4,847 $57,000
Q4 2023 Jan 30, 2024	BUY	$8.77 - $10.85 $166 - $206	19 Added 0.42%	4,541 $49,000
Q4 2022 Feb 03, 2023	SELL	$8.72 - $11.56 $1,081 - $1,433	-124 Reduced 2.67%	4,522 $50,000
Q2 2022 Aug 05, 2022	SELL	$9.95 - $12.27 $258 - $319	-26 Reduced 0.56%	4,646 $49,000
Q1 2022 Apr 11, 2022	SELL	$9.81 - $15.4 $696 - $1,093	-71 Reduced 1.5%	4,672 $51,000
Q4 2021 Feb 07, 2022	SELL	$12.09 - $14.68 $3,288 - $3,992	-272 Reduced 5.42%	4,743 $64,000
Q3 2021 Nov 10, 2021	SELL	$13.25 - $15.13 $371 - $423	-28 Reduced 0.56%	5,015 $68,000
Q2 2021 Jul 20, 2021	SELL	$12.97 - $16.15 $1,413 - $1,760	-109 Reduced 2.12%	5,043 $72,000
Q1 2021 Apr 30, 2021	BUY	$13.59 - $18.54 $1,861 - $2,539	137 Added 2.73%	5,152 $72,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $71,714 - $93,981	5,015 New	5,015 $94,000

Others Institutions Holding VTRS

# of Institutions

1,141

Shares Held

988M

Call Options Held

2.34M

Put Options Held

2.21M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.4B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.

Account

Oakworth Capital, Inc. Viatris Inc Transaction History